Completed OBSERVATIONAL NCT04507191

PDL1 in Ovarian High Grade Serous Carcinoma

Prognostic Value of PDL1 in Ovarian High Grade Serous Carcinoma

Sponsor: Mansoura University Hospital

Interventions immunohistochemical staining

Updated 4 times since 2020 Last updated: Aug 6, 2020 Started: Dec 1, 2012 Primary completion: Dec 1, 2019 Completion: Dec 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Ovarian Cancer and is currently completed. Mansoura University Hospital leads this study, which shows 4 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Sep 2020 — Jan 2021 [monthly]

Completed

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mansoura University Hospital
Port Said University hospital

Data source: Port Said University hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Port Said, Egypt